Patents by Inventor Jérôme Kerzerho

Jérôme Kerzerho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200061173
    Abstract: The present invention relates to immunogenic compositions, in particular, immunogenic compositions comprising at least one peptide derived from survivin, or a functional derivative thereof. Uses of the immunogenic compositions in the treatment of cancer, in particular a cancer over-expressing survivin are also disclosed.
    Type: Application
    Filed: March 15, 2017
    Publication date: February 27, 2020
    Applicant: Vaxeal Research SAS
    Inventors: Ahmed Bouzidi, Jérôme Kerzerho
  • Publication number: 20110159022
    Abstract: A peptide derived from the Midkine protein, comprising at least one CD4+ T or CD8+ T epitope restricted by the HLA molecules predominant in the Caucasian population, or a polynucleotide encoding said peptide, as an anticancer vaccine or as a reagent for immunomonitoring of the cellular response against Midkine over the course of a cancer or of an anticancer treatment.
    Type: Application
    Filed: June 20, 2009
    Publication date: June 30, 2011
    Inventors: Jérôme Kerzerho, Bernard Maillere, Emmanuel Favry